Ad
related to: moderna vaccine effectiveness
Search results
Moderna wins FDA approval for RSV vaccine
BioPharma Dive via Yahoo Finance· 2 days agoThe OK for mResvia adds another option for preventing RSV-related disease in older adults, one year after the agency cleared shots from GSK and Pfizer.
Moderna Looks for Boost From Newly Approved RSV Shot
The Wall Street Journal· 2 days agoThe U.S. Food and Drug Administration approved Moderna’s vaccine to protect against respiratory syncytial virus, or RSV, a common virus that is among the...
COVID Shots Could Use Another Update, Study Suggests
MedPage Today· 4 days agoThe updated monovalent XBB.1.5 COVID-19 vaccines were effective against Omicron subvariants circulating during the most recent respiratory virus season,...
Pfizer says tweaked COVID-19 shots boost omicron protection
KRGV Rio Grande Valley· 3 days agoPfizer announced Saturday that tweaking its COVID-19 vaccine to better target the omicron variant is...
US Nears Deal To Fund Moderna mRNA Bird Flu Shot Trial, Report Says
Forbes· 3 days agoCiting unnamed people close to the discussion, the Financial Times reported federal funding worth...
Researchers are developing an experimental bird flu mRNA vaccine
Quartz· 5 days agoResearchers are developing an mRNA-based vaccine against the contagious H5N1 bird flu virus that is...
Current COVID boosters offer good protection against severe outcomes but less so against JN.1
Center for Infectious Disease Research and Policy· 3 days agoThe authors said the findings underscore the need for new boosters. Next week, the Center for...
FDA Roundup: May 31, 2024
The Pilot News· 2 days agoToday, the FDA approved mRESVIA (Respiratory Syncytial Virus Vaccine) for the prevention of lower respiratory tract disease (LRTD) caused by respiratory syncytial virus (RSV ...
Here are the organizations that Ken Paxton targeted using consumer protection laws
The Texas Tribune· 3 days agoAlso, sign up for The Brief, our daily newsletter that keeps readers up to speed on the most...
Pfizer Stock Is Near An 11-Year Low — But Is It A Buy On This 'Massive' Upside?
Investor's Business Daily· 4 days agoThough it has a booster Covid shot, like rivals Moderna and Novavax, analysts don't expect sales to...
